Clinical Trial Update: Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of Rengalin for acute respiratory viral infection-related cough in children; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection

Drugs mentioned

• Rengalin

Snippet

Sponsor: Materia Medica Holding | Conditions: Cough | Phase 3 | Status: RECRUITING